These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7745115)

  • 1. Immunohistochemical study of topoisomerase II-alpha expression in primary ductal carcinoma of the breast.
    Hellemans P; van Dam PA; Geyskens M; van Oosterom AT; Buytaert P; Van Marck E
    J Clin Pathol; 1995 Feb; 48(2):147-50. PubMed ID: 7745115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of Ki-67 and topoisomerase IIalpha expression in infiltrating ductal carcinoma of the breast. A multivariate analysis of 863 cases.
    Rudolph P; MacGrogan G; Bonichon F; Frahm SO; de Mascarel I; Trojani M; Durand M; Avril A; Coindre JM; Parwaresch R
    Breast Cancer Res Treat; 1999 May; 55(1):61-71. PubMed ID: 10472780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
    Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
    J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
    Stathopoulos GP; Kapranos N; Manolopoulos L; Papadimitriou C; Adamopoulos G
    Anticancer Res; 2000; 20(1A):177-82. PubMed ID: 10769652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
    Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topoisomerase II alpha--a fundamental prognostic factor in breast carcinoma.
    Hajduk M
    Pol J Pathol; 2009; 60(2):67-75. PubMed ID: 19886180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA topoisomerase II-alpha immunoreactivity as a marker of tumor aggressiveness in invasive breast cancer.
    Nakopoulou L; Lazaris AC; Kavantzas N; Alexandrou P; Athanassiadou P; Keramopoulos A; Davaris P
    Pathobiology; 2000; 68(3):137-43. PubMed ID: 11174071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of Topoisomerase II in female breast cancer.
    Koren R; Rath-Wolfson L; Ram E; Itzhac OB; Schachter B; Klein B; Gal R; Dreznik Z
    Oncol Rep; 2004 Oct; 12(4):915-9. PubMed ID: 15375522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of topoisomerase IIIβ expression in breast ductal carcinomas: strong associations with disease-specific survival and metastasis.
    Oliveira-Costa JP; Zanetti J; Oliveira LR; Soares FA; Ramalho LZ; Silva Ramalho F; Garcia SB; Ribeiro-Silva A
    Hum Pathol; 2010 Nov; 41(11):1624-30. PubMed ID: 20950730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topoisomerase II alpha and microtubule-associated protein-tau as a predictive marker in axillary lymph node positive breast cancer.
    Won HS; Lee KE; Sung SH; Choi MY; Jo JY; Nam EM; Mun YC; Seong CM; Lee SN
    Tumori; 2014; 100(1):80-6. PubMed ID: 24675496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of the topoisomerase II alpha and beta genes in human breast cancers.
    Sandri MI; Hochhauser D; Ayton P; Camplejohn RC; Whitehouse R; Turley H; Gatter K; Hickson ID; Harris AL
    Br J Cancer; 1996 Jun; 73(12):1518-24. PubMed ID: 8664122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological Significance of the Proliferation Markers Ki67, RacGAP1, and Topoisomerase 2 Alpha in Breast Cancer.
    Şahin S; Işık Gönül İ; Çakır A; Seçkin S; Uluoğlu Ö
    Int J Surg Pathol; 2016 Oct; 24(7):607-13. PubMed ID: 27284123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerase II alpha expression correlates with diminished disease-free survival in invasive breast cancer.
    O'Connor JK; Hazard LJ; Avent JM; Lee RJ; Fischbach J; Gaffney DK
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1411-5. PubMed ID: 16750309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung.
    Giaccone G; van Ark-Otte J; Scagliotti G; Capranico G; van der Valk P; Rubio G; Dalesio O; Lopez R; Zunino F; Walboomers J
    Biochim Biophys Acta; 1995 Dec; 1264(3):337-46. PubMed ID: 8547322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical detection of DNA topoisomerase type II in primary breast carcinomas: correlation with clinico-pathological features.
    Tuccari G; Rizzo A; Giuffrè G; Barresi G
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(1):51-5. PubMed ID: 8212534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study.
    Yoshioka T; Umekita Y; Ohi Y; Souda M; Sagara Y; Sagara Y; Sagara Y; Rai Y; Tanimoto A
    Histopathology; 2011 Mar; 58(4):608-16. PubMed ID: 21371077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of DNA topoisomerase II alpha expression in small cell and nonsmall cell carcinoma of the lung. In search of a mechanism of chemotherapeutic response.
    Guinee DG; Holden JA; Benfield JR; Woodward ML; Przygodzki RM; Fishback NF; Koss MN; Travis WD
    Cancer; 1996 Aug; 78(4):729-35. PubMed ID: 8756364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in carcinoma of the colon.
    Staley BE; Samowitz WS; Bronstein IB; Holden JA
    Mod Pathol; 1999 Apr; 12(4):356-61. PubMed ID: 10229499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.
    Tokiniwa H; Horiguchi J; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Sato A; Odawara H; Tozuka K; Oyama T; Takeyoshi I
    Breast Cancer; 2012 Oct; 19(4):309-14. PubMed ID: 21725655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of prognostic value of topoisomerase II alpha in patients with breast cancer: analysis with tissue microarray.
    Sheen-Chen SM; Huang CY; Zhang H; Huang CC; Tang RP
    Anticancer Res; 2010 Jun; 30(6):2459-62. PubMed ID: 20651408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.